These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 16216395

  • 1. Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models.
    Saravia NG, Escorcia B, Osorio Y, Valderrama L, Brooks D, Arteaga L, Coombs G, Mottram J, Travi BL.
    Vaccine; 2006 May 08; 24(19):4247-59. PubMed ID: 16216395
    [Abstract] [Full Text] [Related]

  • 2. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.
    Alexander J, Coombs GH, Mottram JC.
    J Immunol; 1998 Dec 15; 161(12):6794-801. PubMed ID: 9862710
    [Abstract] [Full Text] [Related]

  • 3. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
    Zadeh-Vakili A, Taheri T, Taslimi Y, Doustdari F, Salmanian AH, Rafati S.
    Vaccine; 2004 May 07; 22(15-16):1930-40. PubMed ID: 15121305
    [Abstract] [Full Text] [Related]

  • 4. Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.
    Saravia NG, Hazbón MH, Osorio Y, Valderrama L, Walker J, Santrich C, Cortázar T, Lebowitz JH, Travi BL.
    Vaccine; 2005 Jan 11; 23(8):984-95. PubMed ID: 15620471
    [Abstract] [Full Text] [Related]

  • 5. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

  • 6. Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis.
    Fedeli CE, Ferreira JH, Mussalem JS, Longo-Maugéri IM, Gentil LG, dos Santos MR, Katz S, Barbiéri CL.
    Exp Parasitol; 2010 Feb 15; 124(2):153-8. PubMed ID: 19735658
    [Abstract] [Full Text] [Related]

  • 7. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.
    Daneshvar H, Coombs GH, Hagan P, Phillips RS.
    J Infect Dis; 2003 May 15; 187(10):1662-8. PubMed ID: 12721947
    [Abstract] [Full Text] [Related]

  • 8. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice.
    Daneshvar H, Hagan P, Phillips RS.
    Parasite Immunol; 2003 May 15; 25(11-12):589-96. PubMed ID: 15053780
    [Abstract] [Full Text] [Related]

  • 9. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses.
    Pollock KG, McNeil KS, Mottram JC, Lyons RE, Brewer JM, Scott P, Coombs GH, Alexander J.
    J Immunol; 2003 Feb 15; 170(4):1746-53. PubMed ID: 12574338
    [Abstract] [Full Text] [Related]

  • 10. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR.
    Int Immunol; 2005 Oct 15; 17(10):1347-57. PubMed ID: 16141242
    [Abstract] [Full Text] [Related]

  • 11. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity.
    Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, Scott P.
    J Immunol; 2003 Oct 01; 171(7):3711-7. PubMed ID: 14500670
    [Abstract] [Full Text] [Related]

  • 12. Cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana.
    Bart G, Frame MJ, Carter R, Coombs GH, Mottram JC.
    Mol Biochem Parasitol; 1997 Sep 01; 88(1-2):53-61. PubMed ID: 9274867
    [Abstract] [Full Text] [Related]

  • 13. Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5.
    Denise H, Poot J, Jiménez M, Ambit A, Herrmann DC, Vermeulen AN, Coombs GH, Mottram JC.
    BMC Mol Biol; 2006 Nov 13; 7():42. PubMed ID: 17101050
    [Abstract] [Full Text] [Related]

  • 14. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
    Ferreira JH, Gentil LG, Dias SS, Fedeli CE, Katz S, Barbiéri CL.
    Vaccine; 2008 Jan 30; 26(5):677-85. PubMed ID: 18160187
    [Abstract] [Full Text] [Related]

  • 15. A study of cutaneous lesions caused by Leishmania mexicana in plasminogen-deficient mice.
    Maldonado J, Marina C, Puig J, Maizo Z, Avilan L.
    Exp Mol Pathol; 2006 Jun 30; 80(3):289-94. PubMed ID: 16081064
    [Abstract] [Full Text] [Related]

  • 16. LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation.
    Kuhn D, Wiese M.
    Mol Microbiol; 2005 Jun 30; 56(5):1169-82. PubMed ID: 15882412
    [Abstract] [Full Text] [Related]

  • 17. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M, Rivera-Montoya I, Espinoza A, Romero-Grijalva M, López-Flores R, González J, Terrazas LI.
    Cell Immunol; 2006 Aug 30; 242(2):61-71. PubMed ID: 17118349
    [Abstract] [Full Text] [Related]

  • 18. Virulence loss and amastigote transformation failure determine host cell responses to Leishmania mexicana.
    Ali KS, Rees RC, Terrell-Nield C, Ali SA.
    Parasite Immunol; 2013 Dec 30; 35(12):441-56. PubMed ID: 23869911
    [Abstract] [Full Text] [Related]

  • 19. Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis.
    Alves CR, Benévolo-De-Andrade TC, Alves JL, Pirmez C.
    Parasite Immunol; 2004 Mar 30; 26(3):127-35. PubMed ID: 15279623
    [Abstract] [Full Text] [Related]

  • 20. Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana.
    Rosado-Vallado M, Mut-Martin M, García-Miss Mdel R, Dumonteil E.
    Vaccine; 2005 Nov 16; 23(46-47):5372-9. PubMed ID: 16054271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.